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Catfish Herpesvirus (CCV)-Encoded Thymidine Kinase, 
a Selectable Site for Homologous Recombination
Abstract
The channel catfish herpesvirus (CCV) encodes a thymidine 
kinase (Tk) which is biochemically distinguishable from it's 
host, the channel catfish ovary (CCO), and other herpesvirus 
Tk's. Tk deficient CCO cells (CCOBr) were developed by 
propagating CCO cells in increasing concentrations of 5- 
bromo-2'-deoxyuridine (BUdR). CCV infection produced high Tk 
activity in these Tk deficient cells. This activity was 
compared to CCO-Tk in ATP and CTP phosphate donor assays, 
nucleoside substrate-competition and dTTP feedback inhibition 
assays. The viral Tk was more competitively inhibited by 
deoxypurines than cellular Tk and showed less dTTP mediated 
feedback inhibition. CCO-Tk utilized lower concentrations of 
ATP more effectively than CCV-Tk. Neither CCV-Tk nor CCO-Tk 
utilized CTP as a phosphate donor. This is in contrast to 
other herpesvirus Tk's and indicates a divergence from 
mammalian herpesviruses. To map the CCV-Tk gene within the 
CCV genome, a Tk-negative mutant of CCV was isolated by 
passing the virus in the presence of BUdR and then selecting 
an isolate (CCVAr) that was resistant to 1 mM 1-B-D-
arabinofuranosylthymine (Ara-T). A CCV incomplete genomic 
library was constructed by cloning restriction endonuclease 
EcoRI digested viral DNA into plasmid pUC-19. A complete 
library was constructed into cosmid pHC-79 by cloning a 
partial EcoRI digest of viral DNA. Four cosmid clones were 
isolated that collectively encompassed 98% of the genome. The 
cosmid CCV-DNA clones and the pUC-19 subfragments were used 
in cationic-liposome mediated co-transfections with whole 
CCVAr-DNA in marker-rescue assays. CCVAr rescue, scored by 
14CdT mediated plaque autoradiography on CCOBr cells, mapped 
the mutation within the direct repeat ends of the genome.
x
Introduction
Immunization has long been used as a disease control in 
human and veterinary medicine, but only recently has work been 
started on vaccines for aquatic animals. Presently the only 
vaccines registered for aquatic animals are for cold-water 
fish. This is because most cold water operations are 
intensive systems with readily accessible stocks. Work on the 
immunization of warm-water fish and other aquatic animals is 
needed to give aquaculturists another tool to combat disease 
problems and increase production.
Most warmwater aquaculture operations are extensive 
operations containing vast numbers of fish. Individual fish 
have a relatively low value and there is very little direct 
handling of the stocks. Therefore, any successful warm water 
vaccination program must use extensive vaccine delivery 
techniques such as immersion or oral application. Using these 
methods with killed antigen preparations can induce protective 
immune responses in fish, but require large volumes of antigen 
that are taken up in relatively low doses and persist in the 
target animal for a short period. The result is a relatively
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weak and short lasting immune response. Live attenuated 
vaccines are effective immunogens because the attenuated 
pathogen enters the target animal via it's natural invasion 
mode, resulting in efficient uptake. Subsequent replication 
of the agent results in antigen amplification and persistence, 
which induces a stronger, longer lasting response.
Live attenuated vaccines have not been used in 
aquaculture due to the potential of the agent to revert to a 
virulent form. Reversion occurs when the attenuating mutation 
is masked by a second mutation that makes the agent more like 
the wild type pathogen (Almond and Cann, 1984) . 
Traditionally, attenuated viral vaccines have been developed 
by culturing the virus in cells from non-host species or under 
unnatural environmental conditions. This selects for 
mutations that make the pathogen less virulent. Most of these 
mutations are simple base changes which can revert. However, 
recent advances in genetic recombinant technology enable live 
vaccine agents to be constructed which can not revert. 
Pathogens can be permanently attenuated by deletion or 
insertion mutations in genes coding for virulence factors. 
These mutations cannot revert by simple base changes. In 
addition, the insertion and expression of foreign genes in 
these agents have led to a rapid expansion of live vaccine 
research. The techniques that were developed to produce 
recombinant, attenuated poxvirus and herpesvirus vaccine 
vectors for mammalian hosts, can be used to develop a safe
attenuated channel catfish virus vaccine. Furthermore, this 
engineered virus can be used as a vector to express other 
protective immunogens, providing a broad spectrum vaccine for 
the catfish industry.
Effective recombinant viral vaccine vectors require both 
a large genome which can accommodate foreign genes, and a 
selectable genetic site for the insertion of foreign genes. 
The viral thymidine kinase (Tk) gene has been effectively 
exploited as a selectable site of insertion for poxvirus and 
herpesvirus vectors (Shih et al, 1984, Mackett et al., 1984). 
Insertions or deletions of genetic material at the Tk gene 
locus inactivates the Tk gene and results in attenuation (Kit 
et al, 1985a, Kit et al, 1985b, Buller et al, 1985, Roizman 
et al, 1984) .
Channel Catfish Virus (CCV) is a herpesvirus that causes 
disease (CCVD) in young channel catfish fingerlings. CCV can 
cause high mortality, decreased growth, and a predisposition 
of the catfish to bacterial diseases in heavily stocked 
fingerling ponds. Although large juvenile and adult fish are 
susceptible to CCV (Bowser et al., 1985; Hedrick et al., 
1987), CCVD outbreaks are rare in these populations (Plumb, 
1978; McGlamery and Gratzek, 1974). The CCV genome is large 
(130,000 base pairs), suggesting that it can accomodate 
foreign gene insertion. Isolating the CCV Tk gene is the 
first step in constructing a permanently attenuated, Tk 
negative CCV for initial use as a vaccine. Once developed,
the attenuated CCV could be used as a vector for the 
engineering of polyvalent live vaccines against other catfish 
diseases. Accordingly, the purpose of this project was to 
determine if CCV induces Tk activity in the infected cell, to 
distinguish the viral Tk from the cellular Tk, and to locate 
the Tk gene on the genome. In the process, methods for 
producing recombinant CCV was established which will allow the 
production of Tk negative recombinant CCV for vaccine 
research.
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Chapter One 
Literature Review
The channel catfish virus
The channel catfish virus (ictalurid herpesvirus l) is 
an a herpesvirus that can cause significant disease (CCVD) in 
channel catfish (Ictalurus punctatus) fry and young 
fingerlings (Fijan, 1968; Fijan et al., 1970; Wolf and 
Darlington, 1971). The acute form of CCVD can decimate a 
heavily stocked pond of small fingerlings or fry (up to 10cm) 
in 7 days. However, the host range of CCV is very limited. 
The channel catfish is the only known natural host of CCV. 
Fingerling blue catfish (I^ _ furcatus^ and channel x blue 
catfish hybrids can be experimentally infected by 
intraperitoneal injection but are resistant to oral and 
immersion exposures of CCV (Plumb and Chappell, 1978). Brown 
bullheads (1^ . nebulosis) , yellow bullheads (I_-_ natalis) , white 
catfish (I_s_ catus) (Plumb, 1978) , and European sheatfish 
(Silurus glanis) (Plumb et al., 1985) are resistant to oral
and immersion exposures and intraperitoneal injections of CCV.
Disease is characterized by a viremia, with highest 
replication occurring in the head and trunk kidneys and liver. 
Late in the infection titers increase in the intestine and 
brain (Plumb, 1971). Clinical signs include exopthalmia, 
ascites and neurological disorders that induce corkscrew 
swimming. Survivors are considered to be carriers for life 
as indicated by DNA-DNA hybridization studies (Wise and Boyle, 
1985), and reactivation of virus from leukocytes of 
immunosuppressed adult fish (Bowser et al., 1985). Evidence 
strongly suggests vertical transmission of the disease from 
the carriers. Serum neutralization titers from stocks of 
adult channel catfish that produced CCV diseased offspring for 
two consecutive years were 10 to 105 fold higher than control 
fish (Plumb, 1973b). Also, immunoflourescence analysis of 
primary cultures from spent ovarian tissue of suspected CCV 
carriers showed the expression of CCV antigens (Plumb et al., 
1981), suggesting possible transmission of CCV in ovarian 
tissue. Experimental evidence indicates CCVD survivors have 
reduced growth rates. Fingerlings 2 g in size were 
intraperitoneally challenged with CCV and survivors had 
reduced growth rates (McGlamery and Gratzek, 1974). Larger 
unexposed juveniles and adults are susceptible to experimental 
infections and can develop an acute form of disease (Bowser 
et al., 1985; Hedrick et al., 1987) but natural epizootics in 
large fish are rare (McGlamery and Gratzek, 1974; Plumb,
1978;). Recent evidence suggests that CCV may infect many 
fish populations without any overt signs of disease (Wise et 
al., 1985). DNA-DNA hybridization data indicate many catfish 
populations carry the virus even though they have no history 
of CCVD. The expression of overt disease may be dependent on 
high stocking density, predisposing environmental stress 
(McConnell and Austen, 1978; Plumb, 1978) and strain 
susceptibility. Plumb et al. (1975) showed that CCVD
mortality in different strains of channel catfish after oral 
CCV exposure ranged from 10 to 71% with hybrid strains showing 
the lowest mortality. Another factor that may affect disease 
expression is the environmental temperature at the time of 
exposure. Plumb (1973a) showed that at 19 C, CCV produced 
much lower mortalities in fingerlings than at 28 C.
Catfish develop a strong immune response to CCV when 
exposed to live virus. A patented, live, attenuated strain 
of CCV (Noga and Hartman, 1981) was produced by passage 
through walking catfish (Clarius batrachus) cells, Walczache 
et al. (1981) showed significant protection in fry. Awad 
(1988) found that eggs and 1 week old fry were immunized for 
CCVD after exposure to a soluble envelope preparation from 
CCV. However, the characteristics of the protective immunity 
have not been studied. Much research has been focused on 
neutralizing antibody activity in survivors of CCVD, with 
variable results. Fingerlings that have survived outbreaks 
of CCV may or may not produce detectable neutralizing
antibodies (Amend and McDowell, 1983). Some adult survivors 
retain detectable neutralizing antibodies years after the 
productive infection (Plumb, 1973) . Some of the variability 
in production of neutralizing antibodies can be caused by 
differences in the ambient temperature, which affect the 
fish's immune response (Hedrick et al., 1987). Although 
neutralizing antibodies are probably a minor portion of the 
fish's protective immune response to CCV, high titers are an 
indicator of antigen expression from latent infections. Other 
important portions of the antiviral immune response that have 
not been addressed are cytotoxic T lymphocyte responses and 
non-neutralizing antibodies that play a role in antibody 
dependent cell cytotoxicity and complement mediated lysis.
The host specificity of CCV is maintained in cultured 
cells. CCV only replicates in cell lines derived from 
catfish, with the highest titers produced in two Ictalurid 
cell lines. Brown bullhead cells (BB) produce up to 107'5 
PFU/ml (Wolf and Darlington, 1971) and channel catfish ovary 
cells (CCO) produce up to 108 PFU/ml (Bowser and Plumb, 
1980), while walking catfish (Clarius batrachus) cells (K1K) 
produce up to 105,5 PFU/ml (Walczak et al., 1981). The virus 
replicates at temperatures ranging from 10 to 33 C in cell 
culture, with highest titers at 30 C in CCO cells (Bowser and 
Plumb, 1981). CCV induces cytopathic effect (CPE)
characterized by syncytia that contract to clumps with 
radiating spindles.
The replication cycle from adsorption to first infectious 
progeny takes 4 hours at 30 C and as typical of a 
herpesviruses, temporal regulation of protein synthesis and 
a shutdown of host macromolecule synthesis occurs (Dixon and 
Farber, 1980) . Denaturing polyacrylamide gel electrophoresis 
of infected cell extracts has been used to identify at least 
32 unique viral induced proteins. These proteins were 
expressed in three temporal groups and kinetic analyses 
indicate that their synthesis is coordinately regulated (Dixon 
and Farber, 1980). The virion contains 18 of these 
polypeptides. Non-denaturing electrophoretic analysis of 
infected cell lysates (Huston, 1979), and susceptability to 
viral thymidine kinase activated antiherpetic agents (Buck and 
Loh, 1985) indicate this herpesvirus codes for a thymidine 
kinase like other a herpesviruses.
The physical characteristics of the CCV genomic DNA have 
been well characterized. Buoyant density analyses indicate 
the overall base composition is 56% G+C (Goodheart and Pummer, 
1975). Chousterman et al. (1979) used restriction enzyme 
mapping to show the genome is 86 x 106 daltons composed of a 
62 x 106 dalton unique sequence flanked by 12 x 106 dalton 
direct repeats. These results were supported by Dixon and 
Farber (1980) who analyzed the genome by electron microscopy, 
sucrose gradient centrifugation and reassociation kinetics. 
They also found the virus genome contained alkaline labile 
sites similar to other herpesviruses. A comparison of
intracellular and extracellular viral DNA restriction-enzyrae- 
fragment electrophoretic patterns indicates that the 
intracellular replicative DNA does not contain the terminal 
restriction fragments. Instead, it contains a new fragment 
the size of a product produced if the ends of the virion DNA 
molecules were fused (Cebrian et al., 1983). The size of the 
new fragment requires the loss of one of the terminally 
repeated sequences. This "endless" form of replicative DNA 
is a typical form of herpes viral DNA and could be caused by 
a circularization of the viral DNA followed by a rolling 
circle mechanism of replication that produces concatamers that 
are cleaved and packaged into virions. Sequence analysis of 
portions of the 18 kb direct repeats show the following: The
right end of the genome has a 3' single base overhang and the 
left end is blunt. There are sequences with homology to 
putative herpesviruses packaging sequences within 50 bp of 
each end. The repeat region contains an open reading frame 
for a 230 amino acid polypeptide with sequence conservation 
to herpesvirus protein kinases (Lacosa et al., 1989).
Viral Vectors
Much of the early work in molecular virology was 
performed on small DNA viruses, especially the Polyoma SV-40 
group (Sambrook et al., 1973, Sebrung et al., 1971). This 
basic research focused on genome structure, gene regulation
and the function of gene products in infected cells, as well 
as the structure of the genome. Early viral vector research 
concentrated on the small DNA viruses (SV-40 and polyoma) and 
retroviruses (reviewed by Rigby, 1982). These viruses were 
used as eukaryotic expression vectors since no natural 
plasmids occur in higher eukaryotes. This research has been 
important in identifying useful promoter, enhancer and origin 
of replication sequences which led to the development of very 
efficient shuttle vectors. The shuttle vector carries DNA 
sequences that enable it to replicate in prokaryotic and 
eukaryotic cells. Thus, it can be manipulated in vitro, 
amplified in a prokaryotic host, then transferred to a 
eukaryotic host for expression of cloned eukaryotic genes. 
The vector can then be transferred back to a prokaryotic host 
for further manipulations. The basic components of shuttle 
vectors consist of a prokaryotic origin of replication and a 
selection system (generally derived from bacterial plasmids 
or bacteriophage), gene regulatory elements and an origin of 
replication (generally derived from viruses which infect 
eukaryotic cells). By taking advantage of the characteristics 
of each viral system, highly specialized plasmid or viral 
shuttle vectors have been established for transient high level 
expression, stable constitutive expression or stable inducible 
expression in a variety of cell types. Retroviral and 
adeno-associated viral shuttle vectors have been especially 
useful for inserting small sequences of cloned DNA into cell
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genomes.
The current system of choice for producing large amounts 
of eukaryotic proteins is the insect baculovirus system (Emery 
and Bishop, 1987; Luckow and Summers, 1988). Baculoviruses 
are large DNA viruses that produce large intranuclear 
proteinaceous occlusion bodies for protecting the progeny 
virions from adverse environmental conditions. The occlusion 
body protein constitutes 1 mg/ml per 106 cells of infected 
cell cultures and is non-essential. By replacing the 
occlusion body (polyhedrin) gene of Autoaraoha californica 
nuclear polyhedrosis virus (AcMNPV) with the desired foreign 
gene, the foreign gene is expressed in copious amounts. 
Research from mosquito cell lines indicate that the 
post-translational glycosylation in insect cells includes only 
the simple manose rich "backbone" of the complex glycosylation 
found in vertebrates (Buttrose and Hughes, 1981). Yet, the 
recombinant mammalian cell products expressed from 
baculovirus systems are functionally active.
Vaccine Vectors
In the early 1980's, researchers began to use 
recombinant techniques on large DNA viruses to study gene and 
protein functions (Knipe et al., 1978; Moss et al., 1981; Weir 
et al., 1982; Nakano et al., 1982; Sam and Dumbell, 1981). 
It became apparent that members of the poxvirus and 
herpesvirus families were uniquely suited to express large
amounts of genetic information. This property is extremely 
useful for live virus vaccine vectors, because the genes 
encoding protective antigens from several pathogens could be 
expressed in one vector inducing protective immunity to each 
pathogen. Initial research was focused on the vaccinia virus 
of the poxviridae and herpes simplex virus (HSV) of the 
herpesviridae. These viruses were the most characterized of 
their respective families allowing for rapid progress and 
refinement of techniques. Manipulation of genetic sequences 
of these viruses requires the in-vitro manipulation and 
cloning of a viral genomic fragment into E^ _ coli vectors using 
molecular cloning techniques, followed by the transfection of 
this fragment into a live cell containing the replicating 
viral DNA. During the replication process, homologous 
recombination may occur between the viral DNA and the 
unaltered viral sequences flanking the altered DNA in the 
cloned fragment, allowing the insertion of the manipulated 
sequence into a complete viral genome. The most efficient 
recombination systems involve insertion into a selectable 
marker so recombinants can be quickly identified and 
characterized.
The earliest and most commonly used selectable marker 
for insertion is the viral thymidine kinase (Tk) gene 
(Mocarski et al., 1980; Post et al., 1982; Mackett et al., 
1982; Smith et al., 1983). In this system the foreign gene is 
inserted into the Tk gene giving the recombinant virus a Tk
negative phenotype. The Tk negative recombinants can then be 
selected based on their resistance to Tk-activated, toxic 
thymidine analogs such as 5-bromo-2'-deoxyuridine (BUdR). 
Other recombination systems use non-essential glycoprotein 
genes in conjunction with black plaque selection (Saur et al., 
1987) or inserted reporter genes, such as E^ . coli lac Z gene 
with 5-bromo-4-chloro-3-indolyl-D-galactopyranoside (X-gal) 
staining (Spaete and Mocarski, 1987; Panicali et al., 1986) 
as selectable sites of insertion. These systems use visual 
selection to identify the glycoprotein or lac Z negative 
recombinants. An alternative method for selecting recombinant 
viruses is to include a dominant selectable gene as part of 
the insertion sequence, such as host range genes into a host 
range mutant virus (Perkus et al., 1989), neomycin resistance 
gene (Franke et al., 1985) in conjunction with Genticin 148 
selection and E_s_ coli lac Z gene with X-gal color selection 
(Chakrabarti et al., 1985).
Vaccinia virus has been the vector of choice for 
recombinant live virus vaccine research for several reasons: 
1. it has been well established as an effective agent in the 
eradication of smallpox (WHO, 1980) 2. it generally causes
only a localized epidermal infection 3. the virus is 
resistant to desiccation making it a good vaccine agent for 
third world countries where storage problems are common 4. 
it does not establish a latent infection 5. it is 
non-oncogenic 6. it has a large stable genome that can
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accommodate as much as 25,000 bases of foreign sequences 
(Smith and Moss, 1983) 7. it has a broad host range, making
it a candidate for human and veterinary vaccines as well as 
providing non-primate animal models for vaccine research.
The ability of poxviruses to retain their infectivity in 
the environment for prolonged periods and the broad host range 
of vaccinia have hampered field use of recombinant agents due 
to safety concerns. The broad host range also increases the 
threat toman and thus limits the use of vaccinia based 
veterinary vaccines. In rare instances vaccinia can cause 
serious complications especially in very young and 
immunocompromised individuals (Redfield et al., 1987; Lane et 
al., 1969). Researchers have addressed these problems by 
developing vaccine vectors for veterinary use from more 
species specific poxviruses (Esposito et al., 1988; Boyle and 
Coupar, 1986) and by developing less virulent forms of 
vaccinia (Buller et al., 1985; Flexmer et al., 1987; Ramshaw 
et al., 1987).
Research into increasing the efficiency of vaccinia virus 
as a vaccine vector includes increasing the levels of foreign 
gene expression and increasing the immunogenicity of the 
products. Fuerst et al. (1987) obtained high level foreign 
gene expression using a bacteriophage T7-vaccinia hybrid. 
This virus codes for a T7 RNA polymerase and contains the 
foreign gene just below a T7 promoter. The result is an 
extremely high level of foreign gene mRNA production and
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concurrent high level protein expression. Langford et al.
(1986) and Vijaya et al. (1988) have increased the 
immunogenicity of secreted proteins by attaching a 
transmembrane anchor sequence to the gene.
Because of human risk and the ability to establish 
latency, HSV vaccine vectors have met with more skepticism 
than vaccinia vectors. The focus on HSV based vaccine vectors 
has been to establish a safe live vaccine to HSV-1 and HSV-2 
infections as well as immunize humans against other important 
pathogens. Much of this research has been concerned with 
making HSV vectors safe for humans (Roizman et al., 1984; 
Meigner et al., 1988). By inactivating non-essential viral 
genes and subsequently assessing the effects on virulence in 
rodents and lower primates, novel, less virulent vectors which 
have been created (Longnecker et al., 1988). The 
recombination techniques developed by Knipe et al., (1978) 
allowed the pioneering of Tk based deletion and insertion 
systems (Mocarski et al., 1980; Post et al., 1981; Post et 
al., 1982). Early investigations showed that spliced as well 
as unspliced eukaryotic genes could be efficiently expressed 
from HSV vectors (Post et al., 1982). This lead to the 
production of recombinant vectors expressing protective 
antigens from other pathogens for vaccine purposes (Shih et 
al., 1984).
The knowledge gained from initial recombinant research 
has been used in the development of HSV based episomal genetic
elements for gene therapy (Palella et al., 1989; Geller and 
Breakefield, 1988). HSV based gene therapy is especially 
attractive for treatments of genetic nervous disorders such 
as Lesch-Nyhan syndrome which is caused by a rare mutation in 
which the neurons lack dehydrofolate reductase expression. 
The HSV vectors are large enough to accept eukaryotic genes 
containing all of the control elements and splice sequences. 
Also, HSV readily infects and establishes latency in neurons. 
Therefore, the overall goal is to construct replication 
deficient HSV vectors that can infect and establish latency 
as a stable episomal element expressing foreign genes in a 
cell-controlled, regulated fashion.
The techniques developed for HSV research have also been 
applied to other herpesviruses, leading to the development of 
several unique vector systems. The Epstein-Barr virus (EBV) 
has been genetically dissected and important control elements 
have been used to create efficient eukaryotic plasmids with 
wide host ranges (Yates et al., 1985; Jalanko et al., 1988; 
Young et al., 1988;Hammerschmidt and Sugden, 1988). Because 
the EBV derived plasmids are stable in cell culture and can 
express inserted cDNA, they have been used as efficient 
shuttle vectors for screening eukaryotic cDNA libraries 
(Margolskee et al., 1988). In this system, positive cells are 
selected by fluorescent activated cell sorting and cultured 
to increase the number of positive cells. The plasmids are 
then extracted from the cells and transferred into E. coli
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where they are amplified for further analyses.
Recent cytomegalovirus (CMV) research indicates that this 
virus has great potential as an expression vector. As much 
as 1% of the total cellular protein has been expressed from 
foreign genes under the control of 6 2.7 promoter in the CMV 
genome (Spaete and Mocarski, 1987). Because the CMV does not 
contain a Tk gene, an inserted Ej_ coli lac Z gene was used as 
a selectable marker. The CMV used in this research was the 
Towne strain which is attenuated and appears to be incapable 
of establishing latency in human trials. Therefore, the CMV 
recombinants are candidates for human vaccine vectors.
Another non-pathogenic human strain of herpesvirus with 
potential as a vaccine vector is the Oka strain of the 
varicella-zoster virus (VZV). This live virus vaccine strain 
has been shown to be safe even in immunocompromised patients.
Therefore, Lowe et al. (1987) developed a Tk based 
recombination system for this virus with an initial goal of 
establishing a combination VZV-EBV vaccine.
A non-oncogenic deletion construct (Desrosier et al., 
1985a) of the T lymphotrophic 7 herpesvirus, herpesvirus 
saimiri, has been used to express foreign genes in primates 
(Desrosiers et al., 1985b). Because this construct is non- 
pathogenic and readily establishes latency in T lymphocytes, 
researchers are using this vector system for gene therapy and 
immunological studies (Clark, 1987).
The pseudorabies virus (PRV) has been the most studied
herpesvirus candidate for a veterinary vaccine vector. Two 
selectable sites for homologous recombination have been 
identified in PRV: the Tic locus and the glycoprotein X(gX) 
locus. Thymidine kinase negative, bioengineered PRV are 
highly attenuated and effective vaccines for pigs (Kit et al., 
1985a) . The use of the gX insertion in addition to the Tk 
gene site allows the production of a polyvalent vector and 
because the vaccine strain would be gX negative, rapid humoral 
screening could be used to determine if stocks of pigs have 
been exposed to the wild type virus (Thomsen et al., 1987a; 
Marchioli et al. 1987; Thomsen et al., 1987b). Furthermore, 
rearranging the location of an essential gene into the Tk 
locus should prevent any genomic recombination with a wild 
type virus that could make the vector Tk positive (Post and 
Thomsen, 1988). One unique tool developed by Sauer et al.,
(1987) is a bacteriophage P-l Cre-lox mediated, site specific 
insertion system for accurately inserting foreign DNA 
sequences into viral DNA in vitro. Another alternative to in 
vivo insertion of foreign DNA is the manipulation of cloned 
fragments in vitro, then the production of live virus by 
transfecting overlapping cosmid cloned genomic fragments (van 
Zijl et al., 1988).
Other herpesvirus vaccine vector candidates being 
developed for veterinary use are bovine herpesvirus type 1 
(BHV-1) (Kit and Kit, 1986), bovine herpesvirus type-2 (BHV- 
2) (Sheppard and May, 1989), and feline herpesvirus (FHV)
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(Nunberg et al., 1989) . All of these vector systems are based 
on using the Tk gene as a selectable site of recombination and 
as a deletion site for attenuation.
Thymidine Kinase
By coding for a large portion of the metabolic enzymes 
needed for replication, herpesviruses are less dependent on 
host cell functions and can productively infect non­
replicating, differentiated cells such as neurons. Many of 
the non-structural genes that herpesviruses encode are enzymes 
that are important in nucleotide metabolism and DNA 
replication. Herpesviruses have been found to encode a DNA 
polymerase (Weissbach et al., 1973; Boezi et al., 1974),
exonuclease (Preston and Cordingly, 1982), uracil DNA 
glycosylase (Carradonna et al., 1987), deoxyuridine 
triphosphatase (Preston and Fisher, 1984) , dihydrofolate 
reductase (Trimble et al., 1988), ribonucleotide reductase 
(Ponce de Leon, 1977; Dutia, 1983), thymidine kinase (Dubbs 
and Kitt, 1964) and thymidylate synthase (Honess et al, 1986; 
Bodemer et al., 1986). Thymidine kinase is the most studied 
of these enzymes because herpesvirus Tk plays a central role 
in activating several herpesvirus specific antiviral agents 
such as 9-(2-hydroxyethoxymethy1)-guanine, (acyclovir) (Elion 
et al., 1977), 1-B-D arabinofuranosylthymine, (Ara-T)(Aswell 
et al., 1977) and 5-bromodeoxycytosine (Doberson and Greer, 
1978) .
Tk is a pivotal enzyme in the salvage pathway for the 
synthesis of deoxythmidine triphosphate (dTTP), a necessary 
precursor for DNA synthesis. Tk phosphorylates deoxythymidine 
(dT) to deoxythymidine monophosphate (dTMP) which is further 
phosphorylated to dTTP by thymidylate kinase. Eukaryotic 
cells contain two Tk isozymes, a cytoplasmic Tk and a 
mitochondrial Tk (Kit et al., 1973; Lee and Cheng, 1976). 
Cells contain a thymidine transport mechanism on the cell 
membrane (Plageman et al., 1988) to transport the hydrophilic 
thymidine molecule into the cell. Herpesvirus infected cells 
have enhanced uptake of nucleosides via viral induced 
diffusion mechanism, possibly due to increased "leakiness" of 
the cell membrane (Palu et al., 1990).
Of seventeen herpesviruses analyzed, all but 
cytomegalovirus and herpesvirus aotus code encode a Tk (Table 
1) . Generally, herpesvirus encoded thymidine kinases are less 
substrate specific and less regulated than the cellular 
counterparts (Table 1) . The cytoplasmic Tk of eukaryotic 
cells are strongly inhibited by dTTP, do not phosphorylate dC 
or Ara-T and cannot use CTP as a phosphate donor. Herpesvirus 
Tk's are not strongly inhibited by dTTP, they phosphorylate 
Ara-T and can use CTP as a phosphate donor. Some herpesvirus 
Tk's can phosphorylate dC, others cannot. The mitochondrial 
Tk's are more similar to herpesvirus Tk in substrate 
specificity. They are less inhibited by dTTP, phosphorylate 
dC and Ara-T and can utilize CTP as a phosphate donor.
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However, mitochondrial Tk's are strongly inhibited by dCTP.
The low substrate specificity of herpesvirus Tk in 
conjunction with the increased uptake of nucleosides imparts 
the herpesvirus specificity of the nucleoside analog 
antiherpetic agents such as acyclovir, 5-halogenated dC and 
Ara-T. Other large DNA viruses including Poxviridae (Esposito 
et al., 1988; Boyle and Coupar, 1986; Barbanti-Brodano et al., 
1968; Kit et al, 1975) and Iridoviridae (Scholz et al., 1988; 
Aubertine and Longchamps, 1974) also code for viral thymidine 
kinases. Poxvirus Tk is more similar to cytoplasmic Tk in 
substrate specificity (Kit et al., 1975).
In the early 1980's there was a surge of interest in 
viral thymidine kinase isozymes for use as selectable sites 
of homologous recombination. This enzyme is not essential for 
viral replication and Tk negative mutants are resistant to Tk 
activated, antiviral agents. Therefore, the use of the Tk 
gene as a site of foreign gene insertion allows rapid 
selection of recombinants due to their Tk-negative, 
antiherpetic-resistant phenotype. In addition, Tk negative 
mutants were found to be less pathogenic than the wild type 
parent virus. This gave impetus to the development of Tk 
deletion and Tk based recombination systems for viral vaccine 
vectors. To use the Tk gene for recombinant experiments the 
gene must first be located and cloned. Thirteen herpesvirus 
Tk genes have been cloned and sequenced. When amino acid 
sequences of herpesvirus Tk's are compared, only three small
regions of conservation can be located. Only one of these 
regions show homology to the cytoplasmic and poxvirus Tk 
sequences (Figure 1). The amino acid sequences of the Tk's 
have been valuable references in herpesvirus evolutionary 
comparisons. These comparisons have led to the re-evaluation 
of herpesvirus groupings. For example, the turkey herpesvirus 
and Marek's disease virus, once thought to be 7 herpesviruses 
due to their lymphocyte specificity, are now considered more 
related to a herpesviruses (Honess et al., 1989).
Table 1. Characteristics of Thymidine kinase isozymes.
size (daltons) inhibition substrate
monomer active P acceptor P donor
virus dTTP dCTP dC Ara-T CTP
HSV-1, 41,000 low low + + +
HSV-2, 41,000 low low + + +
vzv2i3 35,000 70,000 low + + +
ebv4 low low + + +
EHV-1s 85,000 low - + +
EHV-3e 40,000 83,000 low - +
BHV-17 - + +
hvt8 low low - +
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Figure 1. Amino acid sequence homologies among thymidine 
kinases.
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Chapter Two
Identification and Characterization of a Channel Catfish 
Herpesvirus (CCV) Encoded Thymidine Kinase
Abstract
This investigation demonstrated that channel catfish 
virus (CCV) encodes a thymidine kinase (Tk) which is 
biochemically distinguishable from the Tk of the host cell 
line, channel catfish ovary (CCO), as well as other 
herpesvirus Tk's. A Tk deficient CCO cell line (CCOBr) was 
developed by propagation in increasing concentrations of 5- 
bromo-2'-deoxyuridine. CCV infection of the Tk deficient 
cells produced high Tk activity. CCV was found to be 
sensitive to the Tk activated antiherpetic agent, 1-6-D 
arabinofuranosylthymine (Ara-T). A mutant of CCV (CCVAr), 
isolated by serial passage in BUdR followed by Ara-T, was 
found to be resistant to Ara-T and Tk negative. Extracts of 
CCO and Tk negative cells infected with CCV were assayed for 
differences in competitive inhibition, thymidine triphosphate 
(dTTP) mediated feedback inhibition and phosphate donor 
specificity. CCV-Tk was more competitively inhibited by 
deoxypurines than CCO-Tk and showed less dTTP mediated 
feedback inhibition. CCV-Tk was unique among herpesvirus Tk's 




Thymidine kinase (Tk) phosphorylates thymidine (dT) into 
thymidine monophosphate (dTMP). This reaction is part of the 
salvage pathway for producing thymidine triphosphate (dTTP), 
a necessary precursor for DNA synthesis. The Tk gene is a 
normal component of cells and many large DNA viruses, yet it 
is not essential under normal culture conditions because the 
cell can rely on de-novo dTTP synthesis, where dTTP is 
produced by methylation of deoxyuridine monophosphate. As a 
result the Tk gene can be used as a doubly selectable marker 
for genetic recombination experiments. If supplied dT, Tk 
positive cells and viruses can grow in the presence of 
aminopterin, an inhibitor of de-novo dTTP synthesis. On the 
other hand, Tk negative mutants can be selected by their 
resistance to toxic thymidine analogs, such as 5- 
bromo-2'-deoxyuridine (BUdR), which are activated by Tk 
mediated phosphorylation. In addition, herpesvirus isozymes 
are often less specific than cellular Tk, resulting in the 
selective antiherpetic action of nucleoside based antiviral 
agents such as 1-B-D arabinofuranosythymine (Ara-T) and 
9-(2-hydroxyethoxymethyl) guanine (acyclovir). These agents 
are first phosphorylated by the viral Tk and then cellular 
enzymes phosphorylate the monophosphate compounds to 
triphosphate compounds that interfere with viral DNA
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synthesis.
Tk based selection has greatly facilitated the 
molecular dissection of mammalian herpesviruses. Herpesvirus 
Tk genes have been used as reporter genes to analyze promoter 
elements (Pater and Pater, 1984). Also, Tk genes have been 
used in homologous recombination experiments as selectable 
sites for the insertion of foreign genes (Mocarski et 
al.,1980) and as selectable insertion sequences to interupt 
other viral genes (Post and Roizman, 1981).
Previous work by others (Buck and Loh, 1985: Huston, 
1979) indicated that CCV may encode its own Tk. The purpose 
of this investigation was to confirm the presence of a CCV 
encoded Tk, clearly distinguish it from cellular Tk and to 
develop Tk deficient mutants of CCV and the host cell for 
future marker-rescue based Tk gene mapping.
Materials and Methods 
CCO cells were routinely grown in Dulbecco's modified 
minimal essential medium (DMEM) supplemented with 10% fetal 
calf serum, 25 mM HEPES buffer and 50 jug/ml gentamycin or 100 
IU/ml penicillin and 100 /ig/ml streptomycin. The mutation and 
selection of Tk deficient CCO cells was done by passage in 
medium containing increasing levels of BUdR: 5 mg/1 for 23 
passes, 50 mg/1 for 21 passes, 150 mg/1 BUDr for 7 passes, 250 
mg/1 for 2 passes and 500 mg/1 for 8 passes.
The CCV used in this experiment was the ATCC type strain
4 2
(Auburn clone A) . The sensitivity of CCV to Ara-T was 
determined by comparing the median tissue culture infective 
dose (TCID 50) of a viral suspension in ten fold serial 
dilutions of 1 mM Ara-T to non-exposed controls. An Ara-T 
resistant CCV mutant was selected by passage of the virus in 
the presence of 20 mg/1 BUdR, followed by 50 mg/1 BUdR and 0.1 
mM Ara-T and finally by dilution cloning three times in 0.1 
mM Ara-T.
Cell extracts for Tk analysis were prepared from 
confluent cell sheets in 150 cm2 tissue culture flasks by 
rinsing the cells with Hank's balanced salt solution and 
scraping the cells into 2 ml of ice cold lysis buffer 
containing 10 mM tris (pH 7.5), 10 mM KC1, 1.5 M MgCl2, 0.1 mM 
phenyl-methylsulfonyl flouride (PMSF). Unless otherwise 
specified, viral Tk extracts were prepared in a similar manner 
from confluent Tk negative cells infected with 0.1 plaque 
forming unit (PFU)/cell, and incubated 18 hours at 30 C. The 
cells were lysed by freeze-thawing two times, followed by 
sonication on ice on a Branson Sonifier (Cell Disrupter 200) 
using a microtip with a 50% interval setting at power level 
6 for 30 seconds. The lysate was then mixed with 200 /nl of 
50% glycerol, 1.5M KC1, 12.5mM MgCl2, 3mM 2-mercaptoethanol 
(2ME) and cleared by centrifugation at 100,Q00g for one hour 
at 4 C. The cleared lysates were stored for a maximum of 
three weeks at -70 C for use in Tk assays.
The Tk activity was determined by quantifying the amount
of tritium labeled thymidine (3HdT) phosphorylated by the 
extracts. Basically, equal volumes of cell extract and 
reaction solution (10.6 mM MgCl2, 8 mM KCl, 120 mM Tris pH 
8.0, 0.5 mCi/ml 3HdT, 20 mM ATP, 10 mM NaF, 0.16 mM 2ME) were 
combined, incubated at 27 C for 3 hours and 20 fil of the 
mixture was spotted on a 1 cm2 DEAE paper square. The 
negatively charged 3HdTMP bound to the cationic substrate and 
the unphosphorylated 3HdT was washed off the paper by rinsing 
it three times in 4 mM ammonium formate pH 3.6, three times 
in distilled water, once in 95% ethanol and once with 100% 
ethanol. The paper squares were dried at 60 C for two hours, 
and the bound 3HdTMP quantified by liquid scintillation. In 
all assays 1 mg/ml bovine serum albumin (BSA) was used as a 
negative control. Variations of the above protocol included 
the addition of 0.5, 0.05 or 0.005 mM final concentration of 
BUdR, Ara-T, dT, deoxyadenosine (dA), deoxycytosine (dC), or 
deoxyguanosine (dG) to the reaction mixture for competitve 
inhibition assays, the addition of 0.5, 0.05 or 0.005 mM final 
concentration of deoxythymidine triphosphate (dTTP) to the 
reaction mixture for feedback inhibition assays, and the 
replacement of the 10 mM ATP with 0.5, 1.5, 4.5 or 13.5 mM 




Development of Tk deficient CCO cells.
Normal CCO cells die when cultured in the presence of 25 
mg/1 BUdR within seven passes. However, after 23 passes in 
5 mg/1 BUdR the cells could be continuously cultured in 50 
mg/1 BUdR. After 21 passes in 50 mg/1 BUdR, the cells 
retained a relatively high Tk activity (8270 cpm) compared to 
normal CCO extracts (14,850 cpm). Cells that were 
successively cultured in 150 mg/1 BUdR, 250 mg/1 BUdR and 500 
mg/1 BUdR were resistant to 500 mg/1 BUdR (CCOBr) and had 
significantly reduced Tk activity when compared to normal CCO 
cell extracts (Figure 1).
High Tk activity was found in the Tk negative cells 
infected with CCV (Figure 1) . Tk activity was highest 16 
hours after infecting CCOBr cells with one plaque forming unit 
per cell (figure 2) , at which time the cell sheet was 
characterized by total involvement of the cells in syncytia 
(4+ cytopathic effect).
Sensitivity of CCV to Ara-T and development of a resistant 
mutant.
The infectivity of CCV was reduced 1000 fold in 10'6 M 
Ara-T and was completely eliminated in 10"4 M Ara-T (Figure 3) . 
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Figure 1. Tk activities of CCO cells, CCOBr cells, CCV 
infected CCOBr cells and CCVAr infected CCOBr cells 
(mean+SD). The reactions were run using three extracts 
from each Tk type prepared from 25 cm flasks in a total 
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Hours post infection
Figure 2. The elevation of Tk activity in CCOBr cells as CCV 
infection progresses. CCOBr cells were infected with 1 
PFU/cell and sampled at 0, 2, 4, 8, 10, 12.5, 16 and 18 
hours post infection. All samples were diluted to 700 











log molarity of flraT
Figure 3. Effect of Ara-T on infectivity of CCV. A stock CCV 
culture was dilution plated on CCO cells and incubated 
in medium containing ten fold dilutions of 1 mM Ara-T. 
The tissue culture infective doses (TCID 50) were 
calculated using the methods of Reed and Meunch (1938).
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Ara-T, combined with the induction of Tk activity in Tk 
deficient cells, indicates that CCV contains a Tk gene. 
Subsequent passage of the virus in the presence of BUdR and 
Ara-T resulted in selection of an Ara-T resistant mutant of 
CCV (CCVAr). This mutant virus replicated efficiently in Tk 
negative cells, yet did not induce detectable Tk activity 
(Figure l) . Therefore, CCVAr was considered a thymidine 
kinase deficient CCV mutant.
Characterization of cellular and viral isozvmes
The cellular and viral induced Tk isozymes were compared 
by assessing the nucleoside competitive inhibition profiles, 
ATP and CTP phosphate donor specificity, and dTTP mediated 
feedback inhibition. Unlabelled dT, used as a reference for 
competitive inhibition comparisons, produced significantly 
different inhibition profiles for each isozyme (Figure 4) , 
indicating different enzyme kinetics. Therefore, to simplify 
alternate substrate competitive inhibition analyses, the 
relative percent inhibition by each substrate was determined 
by dividing the inhibition induced by the inhibition induced 
by a similar level of dT (Figure 5) . CCO-Tk and CCV-Tk showed 
similar competitive inhibition profiles for dC. Ara-T and 
BUdR induced inhibition of each isozyme was statistically 
different, but quantitatively similar. The viral Tk was much 




















Figure 4. Competitive inhibition of 3HdT phosphorylation by 
unlabelled dT. Values are expressed in percentage of 
maximum activity. Statistics were performed using the 
Student's T test on arcsin of the square root transformed 





























Figure 5. Relative competitive inhibition of Tk mediated 3HdT 
phosphorylation by thymidine analogs and deoxynucleosides 
in CCO-Tk extracts (O) and CCV-Tk extracts (V). Values 
are expressed in percentage of the inhibition induced by 
a similar concentration of dT. Statistics were performed 
on SAS using the Student's T test on arcsin of the square 
root transformed data to account for non-normal 
distribution of percentage values.
0.027 0.0078 0.84 0.0001 0.000'
0 V 0 V 0 V 0 V 0 V
flra-T BUdR dC dR dG
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Feedback inhibition was more pronounced in the CCO Tk 
than CCV Tk at all levels od dTTP concentration and was 
statistically significant at 0.5 mM dTTP (Figure 6). Both 
isozymes were inefficient at using CTP as a phosphate donor. 
Also, phosphate donor assays showed that the cellular enzyme 
required lower levels of ATP to reach peak Tk activity than 
the viral isozyme (Figure 7).
Discussion
The Tk deficient CCO cell line established in this 
research was pivotal in determining the presence and 
characteristics of the CCV expressed Tk. The CCOBr cell line 
had approximately 10% of the Tk activity of the normal CCO 
cells. A low residual Tk activity due to mitochondrial Tk 
activity is common among BUdR resistant cell lines (Kit et 
al., 1973a; Kit et al., 1973b). The apparent initial BUdR 
resistance of the CCO cells that maintained high Tk activity 
while being continuously cultured in 50ug/ml BUdR may be 
explained by a mutation in the thymidine transport system 
similar to a mutation described in 3HdT resistant Chinese 















Figure 6. A comparison of dTTP feedback inhibition of CCO-Tk 
and CCV-Tk. Values are expressed as a percentage of 
maximum activity. Statistics were performed using the 
Student's T test on arcsin of the square root transformed 


























phosphate donor concentration (mM)
Figure 7. CTP and ATP phosphate donor specificity of CCO-Tk 
and CCV-Tk. Values are expressed in percentage of 
maximum activity. Statistics were performed using the 
Student's T test on arcsin of the square root transformed 
data to account for non-normal distribution of 
percentage values.
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BUdR levels to 500/ig/ml probably induced an additional 
mutation making the cell Tk deficient.
The induction of high Tk activity in CCOBr cells by CCV 
and the production of a mutant virus which does not have a Tk 
inducing activity indicates CCV encodes a thymidine kinase. 
Only 2 of 17 herpesviruses analyzed to date, the human 
cytomegalovirus and herpesvirus aeotus, do not contain a Tk 
gene. Generally herpesvirus Tk's have less restricted 
substrate specificity and dTTP feedback inhibition than the 
cell's cytoplasmic Tk. The phosphate donor specificity, 
competitive inhibition and dTTP mediated feedback inhibition 
assays used in this investigation clearly distinguished the 
cellular Tk from the CCV Tk. Competitive inhibition assays 
were used as indicators of substrate specificity because 
direct measurement of alternate substrate phosphorylation 
would require significant enzyme purification to discount the 
effects of other enzymes. Competitive inhibition profiles 
indicate which substrates bind to the active site and block 
Tk activity, but do not indicate whether the alternative 
substrate is phosphorylated. These investigations showed that 
the cellular Tk used low levels of ATP more efficiently, 
exhibited different enzyme kinetics as indicated in the dT 
inhibition profile, was not competitively inhibited by 
deoxypurines and was more inhibited by dTTP than the viral Tk. 
The ATP and dT profiles indicate cellular Tk has a lower 
processivity and a higher substrate binding activity than the
viral enzyme, making it most efficient in conditions of low 
substrate concentrations. The cellular Tk competitive 
inhibition profiles for Ara-T and dC were high compared to the 
profiles for bovine, equine, rabbit, mouse and human 
cytoplasmic Tk (Turenne-Tessier et al., 1986; Kit and Qavi, 
1983; McGowan et al., 1980; Allen et al., 1979), indicating 
that catfish cytoplasmic Tk may be less specific than 
mammalian Tk and may be a more primitive enzyme. The most 
distinctive feature of the CCV-Tk was its strong competitive 
inhibition by deoxypurines, especially dG. The moderate 
specificity of the cellular Tk to Ara-T and dC in conjunction 
with the selective viral Tk inhibition by deoxypurines 
indicate that deoxypurine analogs such as acyclovir may be 
more selective antiviral agents for CCV than deoxypyrimidine 
analogs such as Ara-T or Ara-C. CCV-Tk was similar to other 
herpesvirus Tk's in nucleoside competitive-inhibition profiles 
and low dTTP inhibition but was unusual in it's low efficiency 
in using CTP as a phosphate donor. The Tk's of other 
herpesviruses such as herpes simplex 1 and 2 (Kit et al., 
1975), Epstein-Barr virus (Turenne- Tesner et al., 1980), 
equine herpesvirus 1 (Weinmaster et al., 1982), herpesvirus 
of turkeys and infectious laryngotracheitis virus (Kit et al., 
1975), characteristically use CTP effectively as a phosphate 
donor. In this respect CCV-Tk is more similar to poxvirus and 
cytoplasmic cellular Tk (Kit et al., 1975).
This investigation demonstrated that CCV encodes a unique
Tk which is clearly distinguishable from cellular Tk activity. 
It also indicated that the CCV-Tk has phosphate donor 
specificity that is unique among herpesvirus Tk's, which, in 
conjunction with the evolutionarily distant nature of the 
host, would make the CCV-Tk gene sequence a uniquely valuable 
reference to compare with higher vertebrate herpes Tk gene 
sequences for enzyme and herpesvirus evolution studies. In 
addition the sequence could be a key reference in studying the 
structure function relationships in the herpesvirus Tk group. 
Research is currently underway using the thymidine kinase 
deficient, CCVAr mutant in marker-rescue assays to locate the 
Tk gene on the CCV genome for subsequent sequence analysis.
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Chapter Three
The Channel Catfish Herpesvirus (CCV) Thymidine Kinase Gene 
is Located in The Terminal Direct Repeat Regions of the Genome
Abstract
The gene encoding the previously identified unique 
channel catfish herpesvirus (CCV) thymidine kinase (Tk) was 
preliminarily located on the CCV genome. CCV genomic DNA 
libraries were constructed into plasmid pUC 19 and cosmid pHC 
79. Analysis of CaCl2, DEAE and cationic liposome mediated 
transfection techniques using /3-galactoside expressing plasmid 
pON 105 on the channel catfish ovary cell line (CCO) , a Tk 
deficient mutant of CCO (CCOBr), and the brown bullhead cell 
line (BB) revealed cationic liposome transfection of CCO cells 
to be most effective combination. More importantly, cationic 
liposome mediated transfection of whole CCV-DNA onto CCO or 
CCOBr cells was the only method that effectively produced 
infectious viral progeny. This is the first account showing 
purified CCV-DNA to be infectious. Subsequently, cationic 
liposome mediated co-transfection of cloned wild type CCV DNA 
with the Tk deficient mutant of CCV (CCVAr) in marker rescue 
assays, mapped the mutation within the 18 Kb direct repeat
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ends of the genome. In addition, the polymerase chain 
reaction, (PCR), was used (Jack Numberg, Cetus Corporation) 
to amplify regions flanked by sequences with homology to 
degenerate primers corresponding to conserved amino acid 
sequences among herpesvirus Tk's. Three PCR generated 
fragments were isolated, cloned into pUC 19 and sequenced. 
The corresponding amino acid sequence of the presumptive 
coding strand of one sequence (405) showed limited homology 
to the mammalian cytoplasmic and poxvirus Tk. A weak specific 
hybridization signal was located on the Eco RI L fragment, 
which is located on the direct repeat ends of the CCV genome, 
when DNA-DNA hybridization analysis was performed using the 
purified 32P nick-translation labelled 405 fragment. The 
combined marker rescue and PCR data map the Tk gene within the 
direct repeat region of the CCV genome. This location is 
unique among herpesviruses, indicating significant divergence 
from previously identified herpesvirus gene arrangements.
Introduction
Because thymidine kinase (Tk), is a non-essential, 
readily detectable, selectable trait in herpesviruses, the 
herpesvirus Tk genes have been the center of much recombinant 
molecular virology research. Herpesvirus Tk genes have been 
used as selectable sites of homologous recombination to insert 
foreign genetic material (Mocarski et al., 1980), as
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selectable insertion sequences to interupt other genes (Post 
and Roizman, 1981), as reporter genes to analyze promoter 
elements (Pater and Pater, 1984) and as reference sequences 
for evolutionary comparisons (Honess et al., 1989). Also, Tk 
deletion mutants have been used as permanently attenuated live 
vaccines.
Recent mutagenesis and enzyme substrate specificity data 
indicate that channel catfish virus (CCV) (Ictalurid 
herpesvirus 1) contains a Tk gene (Chapter Three) that is 
unique among herpesviruses in it's inability to utilize CTP 
as a phosphate donor. The evolutionarily distant host and 
unique enzyme characteristics of this Tk compared to 
previously analyzed herpesviruses Tk's make this gene a 
valuable reference for evolutionary and structure function 
comparisons. In addition, Tk negative mutations in 
herpesviruses generally attenuate the pathogen making them 
suitable as live vaccine agents. The purpose of this 
investigation was to map the viral Tk gene on the CCV genome 
for future evolutionary comparisons and vaccine development.
Materials and Methods
Channel catfish ovary cells (CCO) were grown in 
Dulbecco's modified minimal essential medium (DMEM) 
supplemented with 10% fetal calf serum, 25 mM HEPES buffer and 
100 IU/ml penicillin and 100 ng/ml streptomycin (growth 
medium). The Tk negative mutant of CCO (CCOBr)(Chapter 3) was
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maintained in growth medium supplemented with 500 MS/ml of 5- 
bromo-2'-deoxyuridine (BUdR). The CCV strains used in this 
experiment were the ATCC type strain (Auburn clone A) and a 
Tk negative mutant of this strain, CCVAr (Chapter 3).
Stock virus was produced by infecting CCO cells with 0.01 
plaque forming units per cell, disrupting the cell sheet after 
18 hours at 30 C, freeze thawing the suspension two times and 
storing aliquots at -70 C. Stock CCVAr was produced under 
similar conditions except for the presence of 0.1 mM Ara-T in 
the growth medium. Concentrated virus for DNA isolation were 
produced from roller bottle cultures of CCO cells. Infected 
cells were dislodged from the bottle and centrifuged at 500g 
for 5 minutes at 4 C. The supernatant containing the 
extracellular virus was saved and the pellets were resuspended 
in TNE buffer (10 mM Tris-HCl, 100 mM NaCl, 1 mM EDTA, pH 7.5) 
and lysed by one cycle of freeze thawing, followed by dounce 
homogenization. The cellular debris was again centrifuged at 
3000g for 15 minutes at 4 C and the supernatent containing the 
intracytoplasmic virus was pooled with the extracellular 
virus. The pooled virus was pelleted from the medium at 18,000 
g for one hour at 4 C.
Concentrated virus from 8 roller bottles was purified on 
20 to 60% sucrose gradients at 26,000 rpm in a Beckman SW27 
rotor for 1 hour at 4 C using tritiated thymidine labelled 
virus as a tracer. For library construction, CCV-DNA was 
purified from fractions containing high counts. The fractions
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were digested with 5 fig/ml DNase free RNase, 5^g/ml proteinase 
K in 0.5% SDS at 45 C for 4 hours, followed by gentle 
extraction two times with two volumes of 50 mM Tris, pH 8.0, 
1 mM EDTA saturated, buffered phenol and three times with 
water saturated ether. Residual ether was driven off the 
solution at 70 C for 15 minutes. This solution was dialyzed 
in three changes of TE buffer (10 mM Tris-HCL, 1 mM EDTA, pH 
8.0) at 4 C. Purity of concentrated CCV-DNA was checked by 
agarose gel electrophoresis of Eco RI digested fragments, and 
only fractions producing clean distinct Eco RI restriction 
fragments of CCV were used for subsequent library 
construction.
Infectious CCVAr-DNA was purified by sodium iodide 
gradient centrifugation. The total concentrated virus from 
4 roller bottles were suspended in 15 ml of TNE and digested 
with RNase and proteinase K in SDS as described above. This 
suspension was added to 24 mis of Nal saturated TE buffer 
containing 0.3 mg ethidium bromide and centrifuged at 48,000 
rpm for 40 hours at 20 C in a Beckman VTi 50 rotor. The 
distinct viral DNA band was visible under long wave UV light, 
and was gently harvested using a syringe with a 14 gauge 
needle, gently extracted with isobutanol to remove the 
ethidium bromide, and dialyzed in TE buffer.
An incomplete genomic library of CCV was made by 
digesting purified viral DNA to completion with Eco RI and 
'shotgun' cloning these fragments into the Eco RI site of
plasmid pUC-19. The recombinant plasmids were transformed 
into DH5a E^ _ coli using the calcium chloride method of Hanahan 
(1983). Transformants were isolated on LM agar medium 
containing 50 /xg/ml ampicillin and coated with 2 ng of X-gal. 
White colonies, indicative of transformants containing pUC- 
19 with an insertion in the Lac Z polylinker site, were 
subcultured. The respective plasmids were purified using a 
rapid plasmid isolation procedure (Holmes and Quigley, 1981) 
and then cut with Eco RI. These DNA fragments were analyzed 
by agarose gel electrophoresis. The size of inserted viral 
DNA fragments were compared to the published Eco RI 
restriction map (Chousterman et al., 1979) to determine its 
location on the genome.
A more complete genomic library of CCV was produced by 
cloning a partial Eco RI digest of viral DNA into the cosmid 
pHC-79. First, 12 jug of CCV DNA was digested with 2.4 units 
of EcoRI for 60 minutes in 30 jul at 37 c and 3.6 jug of this 
DNA was mixed with 0.35 jug of calf intestine alkaline 
phosphatase-dephosphorylated Eco RI digested pHC-79 DNA. The 
DNA mixture was ethanol precipitated, reconstituted to 10 jul 
and ligated. This methodology was similar to Maniatis et al. 
(1982). The ligation mixture was subsequently packaged into 
X capsids (Stratagene, Gega Pack Gold, La Jolla, CA) and 
transfected into DH5a E^ . coli. Transformants were selected 
on ampicillin plates and the inserts were analyzed by Eco RI 
digestion followed by agarose gel electrophoresis. The
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corresponding location of the cloned fragments on the CCV 
genome were determined by comparing the Eco RI electrophoretic 
profile to the published Eco RI restriction map of CCV 
(Chousterman et al., 1979).
A comparison of CaCl2, DEAE and cationic liposome 
mediated transfection methods on CCO, CCOBR and brown bullhead 
(Ictalurus nebulosis) (BB) cell lines at 60 to 80% confluency 
in 6 well plates was performed using the plasmid pON 105 which 
contains the E. coli lac Z gene under the control of the 
herpesvirus simplex virus (HSV) immediate early promoter from 
the IE 4 gene (Ho and Mocarski, 1988) . At 72 hours post­
transfection cells were fixed in 0.5% glutaraldehyde in PBS 
for 15 minutes, rinsed three times with PBS (137 mM NaCl, 2.7 
mM KC1, 4.3 mM HP04.7H20, 1.4 mM KH2P04, pH 7.4) then stained 
in a solution of 2.4 mM X-gal, 12.5 mM K3Fe CN6, and 12.5 mM 
K4FeCN6.3H2Q in PBS overnight. /9-galactosidase (B-gal) 
positive transfected cells stained blue and were counted in 
7 fields of view at low power on an inverted microscope (12 
mm2/view). The mean counts of positive staining cells per 
view were divided by the mean number of cells in the viewing 
area to determine the transfection efficiency.
The CaCl2 mediated transfection procedures were 
modifications of Ausubel et al. (1987) . First, 7 /xg of DNA and 
7 of 2.5 M CaCl2 were mixed and diluted to 60 jul with 
distilled water. Sixty /xl of 2X BBS was slowly added under 
constant agitation. This mixture was held at room temperature
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for 20 minutes, diluted with 3 ml of growth medium, and 
dispersed over the cells. Cells were incubated 4 to 5 hours 
at 30 C, shocked for 3 minutes with 15% glycerol or 25% DMSO 
in TBS, rinsed with TBS and overlayed with growth medium. 
Modifications of the above procedures included a DEAE 
pretreatment, in which the cells were rinsed with TBS, 
overlayed with 1.5 ml of 500 /ug/ml DEAE dextran (MW 500,000) 
for 3 minutes and rinsed with TBS before the CaCl2 precipitate 
overlay, or a 100 jiM chloroquine treatment during the the 
incubation with the CaCl2 precipitate.
DEAE dextran transfection procedures followed the methods 
of Ausubel et al.(1987). The cells in each well of a 6 well 
plate were rinsed three times with serum free medium (SFM) and 
overlayed with a mixture of 200 /xg DEAE dextran and 2.5 /xg DNA 
in 1 ml of SFM. After four hours, the cells were either 
glycerol or DMSO shocked as previously described. A 
modification of the above procedure was the addition of 100 
juM Chloroquine to the treatment mixture.
Cationic liposome mediated transfections were performed 
using the Lipofectin reagent (Bethesda Research Laboratories, 
Bethesda, MD) according to the methods described by the 
manufacturer or by method C of Feigner and Holm (1989). 
Marker rescue assays were performed using cationic liposome 
mediated co-transfection of CCVAr-DNA and cloned CCV-DNA by 
a modification of transfection method C of Feigner and Holm 
(1989). Basically, 50 to 70 % confluent CCO cells in a 25 cm2
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tissue culture flask were rinsed 3 times with 1.5 ml of serum 
free growth medium (SFM) and overlayed with 1.5 ml SFM 
containing 50 ng Lipofectin for 30 minutes. Subsequently, 
1.5 ml of SFM containing 5 fig CCVAr DNA and 7 ng cloned CCV- 
DNA was added and incubated at 30 C for 20 hours, after which 
3 ml of growth medium containing 20% FCS was added. 
Cytoplasmic effect (CPE) was usually evident 4 days later, and 
virus was harvested when CPE covered the entire cell sheet.
Tk marker rescue was identified by plating the virus on 
CCOBr cell monolayers on single well glass slides using the 
Tk plaque autoradiography method of Tenser et al. (1983). The 
percentage of recombinants were scored by placing the slide 
on the autoradiograph and comparing the number of plaques with 
a black background to the number of plaques on a light 
background under a dissecting microscope.
Purified CCV-DNA was used in PCR by Dr. Jack Nunberg 
(Cetus Corporation) to amplify regions flanked by sequences 
with homology to degenerate primers corresponding to conserved 
amino acid sequences among herpesvirus Tk's using the primers 
and methods previously described (Nunberg et al., 1989). 
Herpes simplex virus type 1 (HSV-1) and feline herpesvirus l 
(FHV-1) DNA were used as positive controls. The PCR products 
were phenol-ether extracted, ethanol precipitated and 
resuspended in 30 Ml of 5 mM Tris (pH 8.0), 0.1 mM EDTA. Ten 
Ml of each product was separated by vertical 5% polyacrylamide 
gel electrophoresis (PAGE) and stained in 0.5 m 1/ml ethidium
bromide. Bands of apoproximately 330 bp (co-raigrating with 
HSV-1 and FHV-1 Tk specific bands) from CCV PCR products were 
ecxised and placed in 0.5 ml of 0.5 M ammonium acetate for 
elution as described by Maniatis et al. (1982). The eluted 
PCR fragments were Eco RI and Hind III digested and cloned 
into Eco RI, Hind III cut pUC 18 (purified from the polylinker 
fragment by low melt agarose electrophoresis and phenol ether 
extraction) . Plasmids were isolated from /3-galactosidase 
negative transformed colonies using the rapid purification 
method described above, digested with Eco RI and Hind III, and 
analyzed by 5% PAGE. Large scale plasmid extracts were made 
of three clones (405, 409 and 398) containing Eco RI/Hind III 
restriction fragments of the proper size and purified by CsCl2 
gradient centrifugation (Maniatis et al., 1982).
The inserts of purified plasmids were double stranded, 
dideoxyribonucleotide sequenced using a T7 DNA polymerase 
sequencing kit (Sequenase 2.0, United States Biochemical 
Corporation, Cleveland, OH) with M13 positive and negative 
strand primers and a35SATP (1000 Ci/mM) as a label according 
to the manufacturers methods. The reaction mixtures were 
electrophoresed on 35 X 60 cm X 0.4 mm, 6% polyacrylamide- 
urea gels (Gel-Mix 6, Bethesda Research Laboratories, 
Bethesda, MD) at 200 W, 55 C. The gels were dried onto paper 
supports and autoradiographed at room temperature for two days 
using XAR-5 film (Kodak, Rochester, NY).
DNA-DNA hybridization analyses of Eco RI cut, 0.7%
agarose gel electrophoresed CCV and cosmids 395, 394, 389, 388 
DNA were performed using 32P labelled purified inserts of 
plasmids 405 and 409 as probes. The agarose gels were 
electrophoresed at 1 v/cm overnight, then vacuum blotted 
(Trans-vac, Hoeffer Scientific, San Fransisco, CA) onto Gene 
Screen Plus (DuPont Inc., Boston, MA) nylon membranes using 
the methods described by Sambrook et al. (1989). The PCR 
derived inserts were excised from plasmids 409 and 405 by Eco 
RI and Hind III digestion, purified by 5% PAGE and eluted in 
sodium acetate buffer as described earlier. Approximately 7 
ng of each insert were nick translation labelled with a32PCTP 
using the kit NEK-004 (Dupont, Boston, MA) and purified using 
a sephadex G25 spin column. The blots were prehybridized in 
50% formamide, 10% dextran sulfate, 1% SDS, 1 M NaCl and 0.2 
/xg/ml denatured salmon sperm DNA at 42 C for 2 hours followed 
by hybridization at 45 C overnight using one half of the heat 
denatured probe in 10 ml of prehybridized solution. The blots 
were then washed two times in 2X SSC (3 M NaCl, 0.03 M sodium 
citrate, pH 7) at 65 C for 15 minutes, rinsed in SSC, wrapped 
in plastic film and autoradiographed with Kodak XAR-5 film at 
70 C using intensifying screens.
Results
The genomic library developed in pUC19 was incomplete 
because several large fragments, specifically A, C and F, were 
resistant to cloning after several attempts. A more complete
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library was constructed using the cosmid pHC79 system because 
of it's selectivity for larger DNA inserts. Sixteen 
ampicillin resistant transformant colonies were analyzed and 
all contained cosmids with 30 to 40 Kb viral DNA inserts. 
Four unique clones, covering 98% of the genome, were selected 
for the initial marker rescue assays (Figure 1).
The most efficient and reproducible method of 
transfecting CCV permissive cell lines was the cationic 
liposome mediated technique of Feigner and Holme (1989) . This 
method produced 0.1% transfectants in CCO and CCOBr cell 
lines, which was a 10 to 200 fold higher frequency than the 
various CaCl2 and DEAE mediated transfection techniques. BB 
cell transfection experiments consistently produced 
transfection efficiencies at least 10 fold lower than the 
respective CCO and CCOBr transfection experiments. Early 
attempts to produce infectious progeny by CaCl2 mediated 
transfection of CCV-DNA were unsuccessful. However, the first 
cationic liposome mediated transfection of CCOBr cells with 
10 ij, g of CCV-DNA produce infectious CCV progeny. In 
subsequent marker rescue assays using CCVAr-DNA, infectious 
progeny were produced 80% of the time.
Of the four initial cosmids used in marker rescue assays, 
both end cosmids 395 and 389 rescued the CCVAr mutation very 
efficiently. Cosmid 395 induced 67% rescue and 389 induced 82% 
rescue, while cosmids 388 and 394 produced no detectable
in (o ro CO O)
O O ) ( O 0 0 < J > < B c 0 l->








Figure 1. A. Agarose gel electrophoretic profile of Eco RI digested cosmids containing the 
CCV DNA inserts used in marker rescue experiments. The letters on the left designate the 
Eco RI fragments as defined by Chousterman et al., (1979). The right lane contains Hind III 
digested bacteriophage A DNA as size markers, the corresponding sizes in Kb are designated 
adjacent to this lane. B. Location of the CCV DNA inserts of the cosmids in A on the Eco 
RI restriction map (Chousterman et al., 1 ~ 14
plaques from rescue experiments.




rescue (<0.1%). Cosmids 395 and 389 contain DNA from opposite 
ends of the genome and thus contain common sequences from the 
terminal direct repeat region. Subsequently, cosmids 
overlapping the CCV unique portion of cosmid 395, 383 and 386 
(Figure 1), were used in marker rescue and were also found to 
be negative.
Three PCR generated fragments that were produced using 
degenerate Tk primers were cloned into pUC 18 and sequenced. 
The sequence of one fragment (409) corresponded to the FHV-1 
Tk gene and was probably a contaminant generated by the PCR 
reaction or isolated by cross contamination during PAGE 
purification. The corresponding amino acid sequences of the 
presumptive coding strand of fragment 389 showed no homology 
to published Tk sequences and contained several stop codons. 
The deduced amino acid sequence of the presumptive coding 
strand of fragment 405 (Figure 2) showed limited homology to 
vertebrate cytoplasmic and poxvirus Tk sequences (Figure 3). 
Hybridization analyses of Eco RI digested, agarose gel 
electrophoresed CCV and cosmid DNA using PCR generated 
fragments 409 and 405, showed some specific binding of 
fragment 405 to the Eco RI K, L fragments of CCV and the Eco 
RI fragment of cosmid 389 (Figure 4). Fragment 409 showed no 
homology to viral sequences.
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Discussion
This investigation showed that CCV-DNA is infectious, 
established a method for marker rescue analysis of CCV and 
mapped the Tk negative mutation in CCVAr to the terminal 
direct repeat regions of the CCV genome. If this represents 
the Tk gene, the Tk of CCV is diploid. This diploid nature 
would explain the very high percentages of rescue found with 
cosmids 389 and 395 because only 1 of the 2 genes in the 
genome would need to be rescued to impart a Tk positive 
phenotype. A Tk gene located in the repeat regions is unique 
among the herpesviruses thus far investigated. Herpes simplex 
1 and 2 (Wagner et al., 1981; Swain and Galloway, 1983), 
psuedorabies virus (Kit, 1985), bovine herpesvirus 1 and 2 
(Mittal and Field, 1989; Sheppard and May, 1989), Herpesvirus 
saimiri (Honess et al., 1989), marmoset herpesvirus (Otsuka 
and Kit, 1984), varicella zoster virus (Littler et al., 1986), 
herpesvirus of turkeys, Marek's disease virus (Scott et al., 
1989), and Epstein-Barr virus (Littler et al., 1986) all 
contain their respective Tk genes in the unique long regions 
of the genome. Generally the Tks are contained in a gene 
'casette' which also contains the genes coding for the major 
capsid protein and the homolog of HSV glycoprotein H (Albrecht 
and Fleckenstein, 1990; Davison and Taylor, 1987). In other 
a herpesviruses the short repeat regions code for regulatory 
proteins. These results, along with the unique
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G K S T G G K E P R K Q L A T K A A R K
GGAAAATCCACCGGTGGCAAGGAGCCAAGGAAGCAGCTCGCCACTAAGGCTGCCCGCAAG
S A P Y T G G V K K P H R Y K P G T V A
AGCGCACCGTATACCGGCGGTGTGAAGAAGCCTCACCGTTACAAGCCCGGCACCGTGGCT
L R E I R R Y Q K S T E L L I  C K L H F  
CTGAGGGAGATCCGCCGTTATCAGAAGTCTACTGAGCTGCTCATCTGCAAGCTGCACTTC
Q H L V R K I A Q D L K I  D L C F Q X A  
CAGCACCTGGTGAGAAAAATCGCTCAGGACCTCAAGATCGACTTGTGTTTCCAGAGNGCC
L G A L Q E A S E A Y L V G L F E D T N
CTAGGGGCCCTGCAGGAGGCGAGCGAGGCATACCTTGTCGGTCTGTTCGAGGACACCAAC
L C S I H A K G V I G I
CTGTGCTCTATCCACGCCAAGGGAGTGATCGGCATC
Figure 2. The nucleotide sequence and deduced amino acid 














** ** * * * *
IKYSNDNRY___GTGLNTHDKNN FEALEATKLCDVL. E. . .SITDFSVIGI
IKYSNDNRY___GTGLWTHDKNN. . . . FEALEATKLCDVL. EA. . . ITDFSVIGI
VKYEKDIRY___GNGVCTHDNMS ITAVCTPSLDKIDSVA ENAEVIGI
IKYSNDNRY___GTGLWTHDKNN FAALEVTKLCDVL. EA. . . ITDFSVIGI
IKHCGDNRYNEDDINKYYTHDLLF___MEATASSNLSVLVPTLL. . NDGVQVIGI
IKYAKDTRY___SSSFCTHDRNT MEALPACLLRDVAQEAL GVAVIGI
IKYAKDTRY___SNSFSTHDRNT. . . . MDALPACMLRDVTQELL GVAVIGI
VKYAKDTRY. . . CTTGVSTHDRNT___MEARPACALQDVYQEAL____GSAVIGI
Figure 3. A comparison of the deduced amino acid sequence of 
fragment 405 with the amino acid sequences poxvirus and 
vertebrate cytoplasmic Tk's. * indicates regions of 405 
with homology to Tk sequences.
vaccinia virus, Hruby et al., 1983 variola virus, Esposito and Kniaht, 1984 Shope fibroma virus, Upton and 
McFadden, 1986 monkey poxvirus, Esposito and Knight, 1984 fowlpox virus, Boyle et al., 1987 'human, 




Figure 4. DNA-DNA hybridization of Eco RI digested 0.7% 
agarose gel electrophoresed CCV and cosmid DNA using 32P 
labelled PCR fragment 405 as a probe.
substrate specificity of CCV-Tk (Chapter Three) , indicate that 
the channel catfish herpesvirus may show considerable 
divergence from the mammalian herpesviruses. The results of 
the degenerate based PCR experiments provide some support for 
the marker-rescue results. The one sequenced PCR fragment 
that showed some homology to cytoplasmic and poxvirus Tk's 
hybridized to the Eco RI K and L fragments of CCV and to the 
Eco RI L fragment of cosmid 389. These fragments are within 
the direct repeat regions. The PCR data is non definitive 
because the reactions were performed under non-stringent 
conditions and the reactions are sensitive to minute 
quantities of contaminants. If the sequenced PCR product does 
represent the Tk gene, the CCV-Tk is more related to 
vertebrate cytoplasmic and poxvirus Tk's than herpesvirus 
Tk's. Research is currently in progress to sequence this 
region of the genome to confirm the presence of the Tk gene. 
A comparison of CCV-Tk and other viral Tk sequences may give 
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Chapter Four 
The Use of Ciprofloxacin to Cure 
Mycoplasma Contaminated Channel Catfish Ovary Cells
Introduction
Mycoplasmas (MP) are common, yet often inapparent 
contaminants of cell culture. Their effects on cultured cells 
can be subtle or extreme, ranging from altered nutritional 
requirements and changes in physical appearance to metabolic 
changes and altered virus production characteristics (reviewed 
by Barile, 1979). Elimination of mycoplasma contamination is 
essential in any experiments involving detailed analysis of 
cellular enzymes.
During an investigation into cellular and channel catfish 
virus induced thymidine kinase isozymes, MP contamination was 
discovered in both the channel catfish ovary cell line (CCO) 
and a thymidine kinase deficient mutant of the same cells 
(CCOBr). The contaminant evaded detection during initial 
screenings using standard MP culture methods but was detected 
using a commercially available genetic probe to MP ribosomal 
RNA. Schmitt et al. (1988) efficiently eliminated MP from 
mammalian cell lines using the 4-flouroquinalone,
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Ciprofloxacin (CIP). The ability of CIP to cure contaminated 
CCO cell lines was investigated.
Materials and Methods 
All cell lines were routinely passed in Dulbecco's 
modified minimal essential medium + 10% fetal calf serum + 
HEPES buffer + 50 /Ltg/ml gentamicin or 100 IU/ml penicillin and 
100 nq/ml streptomycin. CCOBr cells were cultured in the 
presence of 500 jxq/ml 5-bromo-2'-deoxyuridine. Ciprofloxacin 
tablets were dissociated in distilled water at a concentration 
of 10 mg/ml. This suspension was dissolved in antibiotic free 
growth medium at the appropriate dilution and filter 
sterilized. To find the highest dose of CIP tolerated by CCO 
cells, MP contaminated CCO cells were cultured in the presence 
of 10 /^ g/ml, 50 jLtg/ml and 100 M9/rol CIP for 10 days at 30 C. 
Mycoplasma cultures were prepared by centrifuging antibiotic 
free culture medium from 7 day old cell cultures at 5000g for 
30 min, resuspending the pellet in 100 n 1 of medium and 
inoculating it on modified Hayflick's agar medium (Stalheim, 
1973). To identify any bacterial contaminants in the cell 
cultures, a portion of the centrifuged cell culture medium was 
cultured on 5% blood agar medium at 30 C. Ribosomal RNA based 
hybridization analyses were performed according to the 
manufacturer's recommendations (Mycoplasma T.C., Gene Probe) 
except that 10 ml of tissue culture medium were centrifuged 
for analysis and hybridization times were increased to 16
83
hours to improve sensitivity.
Results
Doses of 50 and 100 /Ltg/ml of CIP produced subleathal 
toxic changes characterized by reduced growth and a flattened 
appearance of the cells. Cells in 10 fig/ml CIP did not 
produce the distinct morphological changes observed in the 
higher doses. Because the 100 Mg/rol dose cells survived, this 
level was used to evaluate the MP elimination. The 100 fig/ml 
CIP treated cells were cultured for two weeks in antibiotic 
free medium and again analyzed for MP. Table 1 shows that CIP 
treated cells were negative for MP while untreated cultures 
and cultures grown in medium containing 50 /xg/ml gentamicin 
remained MP positive. Bacterial screening plates revealed 
tiny <0.5 mm hemolytic colonies on the blood agar after two 
weeks, even though the MP plates grown at 37 C remained 
negative. When replated on MP medium and incubated at 30 C 
instead of the standard 37 C, tiny fried-egg shaped colonies 
characteristic of MP appeared after two weeks. Subsequently, 
CCOBr cells cultured in the presence of 100 ng/ml CIP for 10 
days at 30 C followed by two weeks in antibiotic free media 
were also free of MP contamination. Treated CCO and CCOBr 
cells subcultured in normal growth medium and intermittently 
analyzed for MP contamination remained MP free after 2 or 4.5 
months of continuous culture (Table 1) and were considered 
cured.
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Table 1. Percent Hybridization of Mycoplasma Assays. All 
results above 0.6% are positive. Positive and negative 
controls are supplied by the manufacturer.
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During the 100 mg/ml CIP treatments all cells became 
flattened and grew slowly. Two to three passes in normal 
medium were required for the cells to regain the normal growth 
characteristics.
Discussion
CCO cells are the cell line of choice for studying 
channel catfish virus (CCV) (Bowser and Plumb, 1980). It 
produces higher titers of infectious virus, replicates faster 
and is less sensitive to variables in tissue culture medium 
than other CCV permissive cell lines. Personal communications 
with other labs indicate that mycoplasma contamination is 
prevalent in this cell line, contraindicating the use of these 
cells in enzyme studies. Our results indicate that 
Ciprofloxacin at 100 ng/ml of culture medium can be used to 
effectively eliminate MP contamination from fish cell lines. 
Schmitt et al. (1988) were successful in eliminating 7 
different species of MP from experimentally contaminated 
mammalian cell lines using 10 jug/ml CIP for 10 days at 37 C. 
They found that levels higher than 10 /ng/ml affected protein 
synthesis in specialized cell lines such as hybridomas and 
lymphokine producing tumor cells. In this study the minimal 
inhibiting concentration of CIP on the contaminating MP at 30 
C was not known and the maintanance of a specialized cell type
8 6
was not neccessary. Therefore, contaminated cells were 
cultured in the presence of the highest CIP levels tolerable. 
A gradient of doses of CIP is recommended in treating other 
fish cell lines that may be more sensitive or have specialized 
functions.
The temperature sensitive nature of the MP contaminating 
these piscine derived cell lines indicates a possible piscine 
origin rather than the human, bovine or porcine species that 
commonly contaminate cell cultures. This temperature 
sensitivity also illustrates the need for incubating MP 
diagnostic cultures at the normal incubation temperature for 
the host cell. The genetic probe kit proved to be a simple, 
sensitive and fast method for screening poikilothermic 
vertebrate cell lines for MP and could be used routinely in 
laboratories with access to a liquid scintillation counter.
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Summary
Live vaccine agents should improve the efficiency of 
vaccination for extensive aquaculture programs. Recombinant 
live vaccines can be constructed which are safer, more 
efficient and provide a broader spectrum of protection than 
naturally attenuated pathogens. This research established the 
foundation for developing a channel catfish virus (CCV) based 
vaccine vector system. First, CCV was shown to encode 
thymidine kinase (Tk) . This gene has been shown to be a 
highly efficient selectable and attenuating marker for 
selectable recombination in other herpesviruses. Thymidine 
kinase negative mutants of CCV (CCVAr) and the channel catfish 
ovary (CCO) cell line (CCOBr) were developed that were pivotal 
in identifying and biochemically characterizing the viral Tk. 
Next, the CCV genome was cloned into cosmid and plasmid 
prokaryotic vectors, allowing the viral Tk gene to be mapped 
by identifying the cloned fragments which recombined with the 
Tk negative virus, making it Tk positive. This established 
the methods for producing recombinant CCV, provided a valuable 
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